A common malaria drug could be repurposed to treat a variety of hematologic cancers and solid tumors, according to early ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Comp ...

This approach to nonexclusive licenses focusing on access has successfully demonstrated its use for multiple drugs and diseases. The Medicines Patent Pool, for example, has applied similar ...

Team is now exploring a clinical trial and investigating whether other existing drugs could alleviate endometriosis symptoms ... Fattori and Rogers are inventors on patent PCT/US2023/079238.

The technology claims to identify common drugs of abuse through fingerprint sweat analysis. Credit: Kamon_wongnon / Shutterstock. Intelligent Bio Solutions (INBS) has secured a new US patent for the ...

When a Pharma secures a new drug approval, it typically comes with patent protection, which usually lasts anything from 5-20 years. This prevents competing therapies with a similar mechanism of ...

The Food and Drug Administration on Tuesday approved GSK ... to make up for lost revenues from its best-selling medicines and looming patent losses for its HIV treatments. Over half of all ...

The patent system was designed to promote innovation, and the Hatch-Waxman Act and BPCIA balanced innovation and access to small molecule drugs and biologics. The former president, the USPTO, and ...

Regular pipeline setbacks, slow ramp-up of newer drugs, patent cliffs, regulatory risks and broader market concerns related to the economy are some of the headwinds for the sector. There remains ...

After treatment, the mice stayed seizure-free for two months, according to the paper. Collaborators ... Roopra have also filed for a patent on the use of the drug in epilepsy.

After treatment, the mice stayed seizure-free for two months, according to the paper. Collaborators ... Roopra have also filed for a patent on the use of the drug in epilepsy.

Closed Loop Medicine Ltd., a leader in AI-enabled precision medicines, today announced the expansion of its US patent portfolio ... personalized dosing, novel drug forms and drug-digital ...